Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response.

Prestes JC, Gouveia AG, da Silva MF, Moraes FY, Bines J, Rosa DD, Simon SD, Barrios CH, Werutsky G, Queiroz GS, Morelle A, Mano MS, Cronemberger E, Makdissi FB, Freitas-Júnior R, Couto JD, Emerenciano K, Resende H, Crocamo S, Reinert T, Van Eyil B, Nerón Y, Dybal V, Lazaretti N, Costamilan RC, de Andrade DAP, Mathias C, Vacaro GZ, Borges G, de Jesus RG, Cabalheiro T, Rebelatto TF, Marta GN

Open source

DOI
10.1016/j.clbc.2026.05.001
Published
2026 Jul
Container
Clinical breast cancer
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clbc.2026.05.001,
  title = {Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response.},
  author = {Prestes JC and Gouveia AG and da Silva MF and Moraes FY and Bines J and Rosa DD and Simon SD and Barrios CH and Werutsky G and Queiroz GS and Morelle A and Mano MS and Cronemberger E and Makdissi FB and Freitas-Júnior R and Couto JD and Emerenciano K and Resende H and Crocamo S and Reinert T and Van Eyil B and Nerón Y and Dybal V and Lazaretti N and Costamilan RC and de Andrade DAP and Mathias C and Vacaro GZ and Borges G and de Jesus RG and Cabalheiro T and Rebelatto TF and Marta GN},
  year = {2026},
  journal = {Clinical breast cancer},
  doi = {10.1016/j.clbc.2026.05.001},
  url = {https://doi.org/10.1016/j.clbc.2026.05.001}
}

RIS

TY  - JOUR
TI  - Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response.
AU  - Prestes JC
AU  - Gouveia AG
AU  - da Silva MF
AU  - Moraes FY
AU  - Bines J
AU  - Rosa DD
AU  - Simon SD
AU  - Barrios CH
AU  - Werutsky G
AU  - Queiroz GS
AU  - Morelle A
AU  - Mano MS
AU  - Cronemberger E
AU  - Makdissi FB
AU  - Freitas-Júnior R
AU  - Couto JD
AU  - Emerenciano K
AU  - Resende H
AU  - Crocamo S
AU  - Reinert T
AU  - Van Eyil B
AU  - Nerón Y
AU  - Dybal V
AU  - Lazaretti N
AU  - Costamilan RC
AU  - de Andrade DAP
AU  - Mathias C
AU  - Vacaro GZ
AU  - Borges G
AU  - de Jesus RG
AU  - Cabalheiro T
AU  - Rebelatto TF
AU  - Marta GN
PY  - 2026
JO  - Clinical breast cancer
DO  - 10.1016/j.clbc.2026.05.001
UR  - https://doi.org/10.1016/j.clbc.2026.05.001
ER  - 

APA

JC, P., AG, G., MF, D. S., FY, M., J, B., DD, R., SD, S., CH, B., G, W., GS, Q., A, M., MS, M., E, C., FB, M., R, F., JD, C., K, E., H, R., S, C., T, R., B, V. E., Y, N., V, D., N, L., RC, C., DAP, D. A., C, M., GZ, V., G, B., RG, D. J., T, C., TF, R., & GN, M. (2026). Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response.. Clinical breast cancer. https://doi.org/10.1016/j.clbc.2026.05.001

Source records